Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A study to evaluate pharmacokinetic profile, wearability and safety of AG200-15, transdermal
delivery of levonorgestrel (LNG) and ethinyl estradiol (EE), under normal conditions and
external conditions of heat, humidity, cold water and exercise.